Sars-cov-2
📧 Sign up to get email alerts when something new happens for Sars-cov-2.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Parent Study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOvel Anitbodies (SUPERNOVA Sub-study) [Phase 2, Phase 3]
Clinical trial results for the SUPERNOVA study and its sub-study across Phase 2 and Phase 3 have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants [Phase 2]
A Phase 2 study evaluating the safety, reactogenicity, and effectiveness of Moderna's mRNA-1273.214 vaccine in infants was terminated, and t…
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 [Phase 2]
A Phase 2 trial evaluating interferon lambda as immediate antiviral therapy at diagnosis for COVID-19 has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Ivermectin to Prevent SARS-CoV-2 (COVID-19) Hospitalisation in Subjects Over 50 [Phase 3]
Phase 3 trial investigating ivermectin to prevent COVID-19–related hospitalization in adults over 50 was terminated.
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: FREEDOM COVID-19 Anticoagulation Strategy [Phase 4]
A Phase 4 clinical trial update on the FREEDOM COVID-19 Anticoagulation Strategy in COVID-19/SARS-CoV-2 patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-03Clinical Trial Update: Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults [Phase 3]
Phase 3 passive immunotherapy trial for hospitalized adults with COVID-19 completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-28Clinical Trial Update: NOWDx Test for the Detection of Antibodies to COVID-19 [NA]
Clinical trial update for NOWDx Test detecting antibodies to COVID-19; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise [Phase 2]
A Phase 2 clinical trial evaluating abatacept for hospitalized COVID-19 patients with respiratory compromise was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2022-09-22Clinical Trial Update: Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19 [Phase 2]
Phase 2 pilot trial evaluating ensifentrine versus placebo delivered by inhaler in hospitalized COVID-19 patients; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Stopping ACE-inhibitors in COVID-19 [Phase 4]
Phase 4 clinical trial updating on stopping ACE inhibitors in COVID-19 patients; results posted after completion.
-
CLINICAL_TRIALS research · 2022-07-18Clinical Trial Update: Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing safety, tolerability, and immunogenicity of INO-4800 (DNA vaccine) with electroporation in healthy volunt…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Investigation the Effect of Montelukast in COVID-19 [Phase 2]
Phase 2 clinical trial investigating the effect of montelukast in COVID-19 is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection [Phase 1, Phase 2]
Clinical trial evaluating hyperimmune plasma from convalescent COVID-19 patients (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-04-04Clinical Trial Update: Inpatient Treatment of COVID-19 With Anti-Coronavirus Immunoglobulin (ITAC) [Phase 3]
Phase 3 trial of ITAC, an anti-coronavirus immunoglobulin, for inpatient treatment of COVID-19 has completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-01Clinical Trial Update: Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia [Phase 2]
Phase 2 trial update on convalescent plasma for treating COVID-19 pneumonia; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Study of Sargramostim in Patients With COVID-19 [Phase 2]
Phase 2 clinical trial of sargramostim in COVID-19 patients has been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Inhalation of Ciclesonide for Patients With COVID-19: A Randomised Open Treatment Study (HALT COVID-19) [Phase 2]
Phase 2 randomized open-label trial evaluating inhaled ciclesonide for patients with COVID-19 (HALT COVID-19).
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Repeat Testing for SARS-CoV-2 [NA]
Clinical trial update on repeat testing for SARS-CoV-2 has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 [Phase 2, Phase 3]
An update on effectiveness, safety, and immunogenicity of a half-dose ChadOx1 nCoV-19 (AZD1222) COVID-19 vaccine regimen evaluated in Phase …
-
CLINICAL_TRIALS trial_result · 2021-09-24Clinical Trial Update: Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease [Phase 4]
A Phase 4 clinical trial evaluating valsartan for prevention of acute respiratory distress syndrome in hospitalized COVID-19 patients was te…
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers [NA]
A completed clinical trial evaluating rapid SARS-CoV-2 IgG antibody testing in high-risk healthcare workers. Results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: Azithromycin for COVID-19 Treatment in Outpatients Nationwide [Phase 3]
Phase 3 clinical trial of azithromycin for outpatient treatment of COVID-19 was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19) [Phase 4]
Phase 4 clinical trial update involving an IPV-based approach for SARS-CoV-2 and COVID-19 prevention.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms [Phase 3]
Phase 3 trial evaluating amantadine for prevention of progression and treatment of COVID-19 symptoms; status currently unknown.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Efficacy of Iodine Complex Against COVID-19 Patients [Phase 1, Phase 2]
Trial update indicates ongoing Phase 1/2 evaluation of an iodine complex for COVID-19; status not yet determined.